These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 23815724)
1. Reply: from idiopathic pulmonary fibrosis to cystic fibrosis: got lactate? Kottmann R; Phipps R; Sime P Am J Respir Crit Care Med; 2013 Jul; 188(1):111-2. PubMed ID: 23815724 [No Abstract] [Full Text] [Related]
2. Lactate levels in airways of patients with cystic fibrosis and idiopathic pulmonary fibrosis. Worlitzsch D; Meyer KC; Döring G Am J Respir Crit Care Med; 2013 Jul; 188(1):111. PubMed ID: 23815725 [No Abstract] [Full Text] [Related]
3. Lactate, a novel trigger of transforming growth factor-β activation in idiopathic pulmonary fibrosis. Tuder RM; Lara AR; Thannickal VJ Am J Respir Crit Care Med; 2012 Oct; 186(8):701-3. PubMed ID: 23071184 [No Abstract] [Full Text] [Related]
4. Lactic acid is elevated in idiopathic pulmonary fibrosis and induces myofibroblast differentiation via pH-dependent activation of transforming growth factor-β. Kottmann RM; Kulkarni AA; Smolnycki KA; Lyda E; Dahanayake T; Salibi R; Honnons S; Jones C; Isern NG; Hu JZ; Nathan SD; Grant G; Phipps RP; Sime PJ Am J Respir Crit Care Med; 2012 Oct; 186(8):740-51. PubMed ID: 22923663 [TBL] [Abstract][Full Text] [Related]
5. EZH2 enhances the differentiation of fibroblasts into myofibroblasts in idiopathic pulmonary fibrosis. Xiao X; Senavirathna LK; Gou X; Huang C; Liang Y; Liu L Physiol Rep; 2016 Sep; 4(17):. PubMed ID: 27582065 [TBL] [Abstract][Full Text] [Related]
6. Myofibroblast differentiation and enhanced TGF-B signaling in cystic fibrosis lung disease. Harris WT; Kelly DR; Zhou Y; Wang D; MacEwen M; Hagood JS; Clancy JP; Ambalavanan N; Sorscher EJ PLoS One; 2013; 8(8):e70196. PubMed ID: 23950911 [TBL] [Abstract][Full Text] [Related]
7. The hedgehog system machinery controls transforming growth factor-β-dependent myofibroblastic differentiation in humans: involvement in idiopathic pulmonary fibrosis. Cigna N; Farrokhi Moshai E; Brayer S; Marchal-Somme J; Wémeau-Stervinou L; Fabre A; Mal H; Lesèche G; Dehoux M; Soler P; Crestani B; Mailleux AA Am J Pathol; 2012 Dec; 181(6):2126-37. PubMed ID: 23031257 [TBL] [Abstract][Full Text] [Related]
8. Novel differences in gene expression and functional capabilities of myofibroblast populations in idiopathic pulmonary fibrosis. Walsh SM; Worrell JC; Fabre A; Hinz B; Kane R; Keane MP Am J Physiol Lung Cell Mol Physiol; 2018 Nov; 315(5):L697-L710. PubMed ID: 30091381 [TBL] [Abstract][Full Text] [Related]
9. The impact of TGF-β on lung fibrosis: from targeting to biomarkers. Fernandez IE; Eickelberg O Proc Am Thorac Soc; 2012 Jul; 9(3):111-6. PubMed ID: 22802283 [TBL] [Abstract][Full Text] [Related]
10. Sustained activation of toll-like receptor 9 induces an invasive phenotype in lung fibroblasts: possible implications in idiopathic pulmonary fibrosis. Kirillov V; Siler JT; Ramadass M; Ge L; Davis J; Grant G; Nathan SD; Jarai G; Trujillo G Am J Pathol; 2015 Apr; 185(4):943-57. PubMed ID: 25660181 [TBL] [Abstract][Full Text] [Related]